Last reviewed · How we verify
Zoxine (ZOXAZOLAMINE)
Zoxine (generic name: ZOXAZOLAMINE) is a drug. It is currently in Phase 2 development.
Zoxine works by interacting with a specific target in the body to produce a desired effect.
Zoxine is a small molecule with the synonyms CONTRAZOLE, DEFLEXOL, FLEXIN, MCN-485, MIAZOL, and NSC-24995.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | ZOXAZOLAMINE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 2 |
Mechanism of action
Unfortunately, there is not enough information available to provide a clear explanation of how Zoxine works. However, in general, small molecule compounds like Zoxine work by binding to a specific target, such as a protein or receptor, which triggers a series of chemical reactions that ultimately produce the desired effect. This can be thought of as a key fitting into a lock, where the key is the small molecule and the lock is the target.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zoxine CI brief — competitive landscape report
- Zoxine updates RSS · CI watch RSS
Frequently asked questions about Zoxine
What is Zoxine?
How does Zoxine work?
What is the generic name of Zoxine?
What development phase is Zoxine in?
Related
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing